Your first read has lousy quality scores, and its best blast to mouse has several discrepancies. That's why it won't align. The second read should align fine.
rs4244385 is a human SNP.
Unconfigured Ad
Collapse
X
-
Help!
anyone?????Originally posted by andrehorta View PostI used the command: bowtie -p 4 /rs4244385A
And reads that failed to align: (100.00%)
Can help me?
Leave a comment:
-
I used the command: bowtie -p 4 /rs4244385A
And reads that failed to align: (100.00%)
Can help me?
Leave a comment:
-
Hello fkrueger,
I've never tried this software but I will now, it looks very useful.
Thank you,
Michy
Leave a comment:
-
May I ask if you used FastQC on your sequence files to find out whether you are sequencing into the adapter on the other side? This might throw mapping efficiencies off quite a bit and can be fixed by trimming adapter sequences off or just shortening the sequences a bit.
Leave a comment:
-
Hello fkrueger,
thank you for your reply. Your suggestions esp. a) and c) they did improve the alignment by 15% which means 85% still failed to align. However, I was testing the command on a small subset of the data. I will try some more reads and get back to you.
Thank you again and any other suggestions welcome.
Michy
Leave a comment:
-
Hi michy,
The command you used looks ok-ish, but
(a) -q is the default, however Bowtie will then assume Phred33 qualities. The HiSeq seems to chuck out Phred64 encoded data though, try specifiying -q --phred64-quals
(b) -I 0 is not not required as it is the default
(c) If you still don't get any alignments you might want to increase -X to a higher value, maybe your insert sizes are just larger than 300bp?
Hope (a) or (c) will fix it.
Leave a comment:
-
Bowtie and reads that failed to align: (100.00%)
Hello,
Can someone help me please. I have some new paired-end sequence from illumina and the reads are not aligning. What am I doing wrong? An example of the reads are below with the commandline I am using. I would be grateful for any help, cheers.
Read from sequence file #1
@HISEQ2000_0110:4:68:14837:199814#GGGCGG/1
GCTCCAGTATAGGGGAATGCCAGGACTAGGAAGAGGGATTGTGTGGTTTGGAGAGCAGGACGGAGGGAGGGTATACGTCACTATGAGATGGGAAACTTGTA
+HISEQ2000_0110:4:68:14837:199814#GGGCGG/1
ccccc_ca\c[[]X]JYJVRRHSXHMMNYVPVZEIWFFYXXZ_Z]cbccb_J[G_VPZUF^X`H`^YD`BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
@HISEQ2000_0110:4:68:14861:199831#GCACTG/1
Read from sequence file #2
@HISEQ2000_0110:4:68:14837:199814#GGGCGG/2
CACTTTAAAATCTATTTGATCTTGAGGAAATCAGTTGTGTTTCCTAGTTATATAGTCTATCATTTAATAATAGCACTAATGAAGTGTTTAGAAGTAATAAT
+HISEQ2000_0110:4:68:14837:199814#GGGCGG/2
ggggggggggfbfIffffefggggeggggeU^cf_eedfee^ZZ\accdd]eeeeffedfI[bbbcYccbeaeddgggaedTcc_dbfdIc\c\P_ZM_BB
Commandline
./bowtie -t -p 14 -q -I 0 -X 300 -S --chunkmbs 2048 mus -1 ../working/s_temp_1.txt -2 ../working/s_temp_2.txt ../working/s_temp_aligned.sam
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Genome Sequencing Reveals Large, Repeat-Rich DNA in Trapdoor Spider Named for Stephen Colbert
by SEQadmin2
Started by SEQadmin2, Yesterday, 09:57 AM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 09:57 AM
|
||
|
Started by SEQadmin2, Yesterday, 09:51 AM
|
0 responses
11 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 09:51 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
67 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
47 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
Leave a comment: